Mechanisms underlying coagulation abnormalities in ebola hemorrhagic fever: Overexpression of tissue factor in primate monocytes/macrophages is a key event

被引:276
作者
Geisbert, TW
Young, HA
Jahrling, PB
Davis, KJ
Kagan, E
Hensley, LE
机构
[1] USA, Div Virol, Med Res Inst Infect Dis, MCMR UIV, Ft Detrick, MD 21702 USA
[2] USA, Headquarters, Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA
[3] NCI, Cellular & Mol Immunol Sect, Expt Immunol Lab, Frederick Canc Res & Dev Ctr, Frederick, MD 21701 USA
[4] Uniformed Serv Univ Hlth Sci, Dept Pathol, Bethesda, MD 20814 USA
关键词
D O I
10.1086/379724
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Disseminated intravascular coagulation is a prominent manifestation of Ebola virus (EBOV) infection. Here, we report that tissue factor l plays an important role in triggering the hemorrhagic complications that characterize EBOV infections. Analysis of samples obtained from 25 macaques showed increased levels of TF associated with lymphoid macrophages, whereas analysis of peripheral blood-cell RNA showed increased levels of TF transcripts by day 3. Plasma from macaques contained increased numbers of TF-expressing membrane microparticles. Dysregulation of the fibrinolytic system developed during the course of infection, including a rapid decrease in plasma levels of protein C. Infection of primary human monocytes/macrophages (PHMs) was used to further evaluate the role of TF in EBOV infections. Analysis of PHM RNA at 1-48 h showed increased TF transcripts, whereas levels of TF protein were dramatically increased by day 2. Thus, chemotherapeutic strategies aimed at controlling overexpression of TF may ameliorate the effects of EBOV hemorrhagic fever.
引用
收藏
页码:1618 / 1629
页数:12
相关论文
共 51 条
[1]   Detection of mononuclear cells as the source of the increased tissue factor mRNA in the liver from lipopolysaccharide-treated rats [J].
Arai, A ;
Hirano, H ;
Ueta, Y ;
Hamada, T ;
Mita, T ;
Shirahata, A .
THROMBOSIS RESEARCH, 2000, 97 (03) :153-162
[2]   Efficacy and safety of recombinant human activated protein C for severe sepsis. [J].
Bernard, GR ;
Vincent, JL ;
Laterre, P ;
LaRosa, SP ;
Dhainaut, JF ;
Lopez-Rodriguez, A ;
Steingrub, JS ;
Garber, GE ;
Helterbrand, JD ;
Ely, EW ;
Fisher, CJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) :699-709
[3]   Tissue factor as a proinflammatory agent [J].
Bokarewa, MI ;
Morrissey, JH ;
Tarkowski, A .
ARTHRITIS RESEARCH, 2002, 4 (03) :190-195
[4]   Haematological, biochemical and coagulation changes in mice, guinea-pigs and monkeys infected with a mouse-adapted variant of Ebola Zaire virus [J].
Bray, M ;
Hatfill, S ;
Hensley, L ;
Huggins, JW .
JOURNAL OF COMPARATIVE PATHOLOGY, 2001, 125 (04) :243-253
[5]  
Burke J, 1978, B WORLD HEALTH ORGAN, V56, P271
[6]  
Davis KJ, 1997, ARCH PATHOL LAB MED, V121, P805
[7]  
DRAKE TA, 1993, AM J PATHOL, V142, P1458
[8]  
EGBRING R, 1971, P41
[9]   Protein C anticoagulant pathway and its role in controlling microvascular thrombosis and inflammation [J].
Esmon, CT .
CRITICAL CARE MEDICINE, 2001, 29 (07) :S48-S51
[10]   Regulation of blood coagulation [J].
Esmon, CT .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 2000, 1477 (1-2) :349-360